Analysis of Vasomotor Symptoms in Perimenopausal Women Based on the Menopause Rating Scale (MRS)

Yudita Ingga Hindiarti, Silvia Widyani Heriyanti, Sri Heryani, Siti Farichatul Aliyah

Abstract

Background: Perimenopause is a transitional phase experienced by women before menopause and is often accompanied by vasomotor symptoms such as hot flushes, excessive sweating, and sleep disturbances. Vasomotor symptoms may affect women’s quality of life physically and psychologically. Menopause Rating Scale (MRS) is an internationally standardized instrument frequently used to assess menopause symptoms. Aim: This study aimed to describe vasomotor symptoms among perimenopausal women using Menopause Rating Scale (MRS). Methods: This study used a descriptive quantitative design with a cross-sectional approach. The participants were women aged 40–55 years experiencing perimenopausal symptoms. Data were collected using the Menopause Rating Scale (MRS) questionnaire. Sampling was conducted using consecutive sampling. Data analysis was performed descriptively to identify the distribution and severity of vasomotor symptoms. Results: Most respondents experienced moderate vasomotor symptoms characterized by hot flushes, night sweats, and sleep disturbances. Several respondents also reported psychological complaints accompanying vasomotor symptoms. The MRS instrument was able to identify the severity level of symptoms experienced by respondents effectively. Conclusion: Vasomotor symptoms are commonly experienced by perimenopausal women and may affect their quality of life. The use of MRS is useful for early identification and monitoring of menopause symptoms among women in primary health care settings.

Keywords

Perimenopause; Vasomotor Symptoms; Menopause Rating Scale

Full Text:

PDF

References

Antari, N., Herliana, S., & Fitria, N. (2024). Perimenopause symptoms and women’s quality of life. Journal of Women Health, 12(2), 100–108.

Avis, N. E., Crawford, S. L., & Green, R. (2015). Vasomotor symptoms across the menopause transition: Differences among women. Obstetrics and Gynecology Clinics, 42(2), 163–180. https://doi.org/10.1016/j.ogc.2015.01.005

Baber, R. J., Panay, N., & Fenton, A. (2016). IMS recommendations on women’s midlife health and menopause hormone therapy. Climacteric, 19(2), 109–150. https://doi.org/10.3109/13697137.2015.1129166

Freeman, E. W., Sammel, M. D., & Lin, H. (2011). Symptoms associated with menopausal transition and reproductive hormones. Obstetrics & Gynecology, 117(3), 624–632. https://doi.org/10.1097/AOG.0b013e31820ce18d

Greene, J. G. (1998). Constructing a standard climacteric scale. Maturitas, 29(1), 25–31.

Heinemann, L. A. J., Potthoff, P., & Schneider, H. P. G. (2003). International versions of the Menopause Rating Scale (MRS). Health and Quality of Life Outcomes, 1(1), 28. https://doi.org/10.1186/1477-7525-1-28

Hilditch, J. R., Lewis, J., Peter, A., van Maris, B., Ross, A., Franssen, E., & Guyatt, G. H. (1996). A menopause-specific quality of life questionnaire: Development and psychometric properties. Maturitas, 24(3), 161–175.

Kartini, D. (2020). Menopause syndrome among Indonesian women. Indonesian Journal of Midwifery, 8(1), 45–52.

Kementerian Kesehatan Republik Indonesia. (2020). Profil kesehatan Indonesia tahun 2020. Jakarta: Kementerian Kesehatan RI.

Monteleone, P., Mascagni, G., Giannini, A., Genazzani, A. R., & Simoncini, T. (2018). Symptoms of menopause—Global prevalence, physiology and implications. Nature Reviews Endocrinology, 14(4), 199–215.

Nainggolan, R., & Iliwandi, A. (2023). Women’s health and menopause transition. International Journal of Public Health Research, 5(3), 77–84.

Nurlina, N. (2021). Kesehatan psikologis perempuan menopause. Jurnal Kesehatan Reproduksi, 10(1), 55–63.

Purnamasari, K. D., & Hindiarti, Y. I. (2023). The effect of women’s health education on reproductive health awareness among middle-aged women. International Journal of Nursing and Health Services, 6(5), 303–308.

Santoro, N., Epperson, C. N., & Mathews, S. B. (2015). Menopausal symptoms and their management. Endocrinology and Metabolism Clinics, 44(3), 497–515.

Siregar, M., et al. (2024). Menopause prevalence and women’s reproductive health in Indonesia. Journal of Community Health, 9(1), 12–20.

Soules, M. R., Sherman, S., Parrott, E., Rebar, R., Santoro, N., Utian, W., & Woods, N. (2001). Executive summary: Stages of reproductive aging workshop (STRAW). Fertility and Sterility, 76(5), 874–878.

Speroff, L., & Fritz, M. A. (2005). Clinical gynecologic endocrinology and infertility (7th ed.). Philadelphia: Lippincott Williams & Wilkins.

Trisetiyaningsih, Y., Azizah, N., & Utami, S. (2023). Keluhan fisik dan psikologis perempuan perimenopause. Jurnal Kebidanan dan Kesehatan Tradisional, 7(2), 90–98.

Utian, W. H. (2005). Psychosocial and socioeconomic burden of vasomotor symptoms in menopause. Climacteric, 8(Suppl 1), 3–9.

WHO. (2023). Women ageing and health report. Retrieved from https://www.who.int

Woods, N. F., Mitchell, E. S., & Smith-DiJulio, K. (2009). Is the menopausal transition stressful? Observations of perceived stress from the Seattle Midlife Women’s Health Study. Menopause, 16(1), 90–97.

Yusuf, S., & Rahmawati, D. (2022). Gambaran gejala menopause pada perempuan usia menengah. Jurnal Kebidanan Indonesia, 13(2), 88–96.

Ziv-Gal, A., & Flaws, J. A. (2016). Factors that may influence the experience of hot flushes by healthy middle-aged women. Journal of Women’s Health, 25(4), 341–349.

DOI: http://dx.doi.org/10.25157/ihc.v2i1.25809

Refbacks

  • There are currently no refbacks.